Northern Trust’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.2M | Buy |
781,418
+19,945
| +3% | +$596K | ﹤0.01% | 1581 |
|
|
2025
Q4 | $29.1M | Sell |
761,473
-70,606
| -8% | -$2.3M | ﹤0.01% | 1431 |
|
|
2025
Q3 | $19.9M | Buy |
832,079
+31,451
| +4% | +$591K | ﹤0.01% | 1688 |
|
|
2025
Q2 | $11.8M | Sell |
800,628
-8,059
| -1% | -$134K | ﹤0.01% | 1965 |
|
|
2025
Q1 | $14.5M | Buy |
808,687
+54,292
| +7% | +$1.1M | ﹤0.01% | 1823 |
|
|
2024
Q4 | $13.1M | Buy |
754,395
+76,358
| +11% | +$1.35M | ﹤0.01% | 1966 |
|
|
2024
Q3 | $9.49M | Sell |
678,037
-26,525
| -4% | -$276K | ﹤0.01% | 2096 |
|
|
2024
Q2 | $5.79M | Sell |
704,562
-19,467
| -3% | -$131K | ﹤0.01% | 2316 |
|
|
2024
Q1 | $5.58M | Sell |
724,029
-6,117
| -0.8% | -$51.6K | ﹤0.01% | 2381 |
|
|
2023
Q4 | $6.56M | Buy |
730,146
+40,126
| +6% | +$292K | ﹤0.01% | 2335 |
|
|
2023
Q3 | $6.17M | Buy |
690,020
+5,887
| +0.9% | +$83.1K | ﹤0.01% | 2314 |
|
|
2023
Q2 | $10.5M | Sell |
684,133
-6,768
| -1% | -$123K | ﹤0.01% | 2028 |
|
|
2023
Q1 | $15.5M | Buy |
690,901
+54,176
| +9% | +$1.15M | ﹤0.01% | 1721 |
|
|
2022
Q4 | $13.4M | Buy |
636,725
+4,580
| +0.7% | +$97.1K | ﹤0.01% | 1810 |
|
|
2022
Q3 | $15.6M | Sell |
632,145
-4,369
| -0.7% | -$113K | ﹤0.01% | 1673 |
|
|
2022
Q2 | $15.4M | Buy |
636,514
+10,254
| +2% | +$258K | ﹤0.01% | 1717 |
|
|
2022
Q1 | $16.1M | Buy |
626,260
+70,464
| +13% | +$1.87M | ﹤0.01% | 1821 |
|
|
2021
Q4 | $17.3M | Sell |
555,796
-4,819
| -0.9% | -$136K | ﹤0.01% | 1880 |
|
|
2021
Q3 | $13.6M | Sell |
560,615
-58,130
| -9% | -$1.07M | ﹤0.01% | 2063 |
|
|
2021
Q2 | $9.03M | Sell |
618,745
-22,176
| -3% | -$437K | ﹤0.01% | 2445 |
|
|
2021
Q1 | $16M | Buy |
640,921
+26,024
| +4% | +$719K | ﹤0.01% | 1984 |
|
|
2020
Q4 | $16.8M | Sell |
614,897
-19,072
| -3% | -$445K | ﹤0.01% | 1923 |
|
|
2020
Q3 | $11.7M | Buy |
633,969
+39,635
| +7% | +$770K | ﹤0.01% | 2014 |
|
|
2020
Q2 | $12.1M | Buy |
594,334
+30,420
| +5% | +$484K | ﹤0.01% | 1987 |
|
|
2020
Q1 | $8.23M | Buy |
563,914
+5,663
| +1% | +$85.2K | ﹤0.01% | 1998 |
|
|
2019
Q4 | $7.93M | Buy |
558,251
+4,203
| +0.8% | +$53.7K | ﹤0.01% | 2327 |
|
|
2019
Q3 | $6.42M | Buy |
554,048
+20,971
| +4% | +$347K | ﹤0.01% | 2403 |
|
|
2019
Q2 | $10.7M | Buy |
533,077
+2,880
| +0.5% | +$56.9K | ﹤0.01% | 2109 |
|
|
2019
Q1 | $12M | Sell |
530,197
-230,299
| -30% | -$5.09M | ﹤0.01% | 2031 |
|
|
2018
Q4 | $17.2M | Buy |
760,496
+4,277
| +0.6% | +$106K | ﹤0.01% | 1697 |
|
|
2018
Q3 | $21.7M | Sell |
756,219
-2,374
| -0.3% | -$67.9K | 0.01% | 1732 |
|
|
2018
Q2 | $20.7M | Buy |
758,593
+45,069
| +6% | +$1.2M | 0.01% | 1758 |
|
|
2018
Q1 | $16M | Buy |
713,524
+12,513
| +2% | +$298K | ﹤0.01% | 1859 |
|
|
2017
Q4 | $14.8M | Sell |
701,011
-12,336
| -2% | -$282K | ﹤0.01% | 1934 |
|
|
2017
Q3 | $17.8M | Buy |
713,347
+5,099
| +0.7% | +$112K | ﹤0.01% | 1792 |
|
|
2017
Q2 | $13.7M | Buy |
708,248
+26,119
| +4% | +$474K | ﹤0.01% | 1957 |
|
|
2017
Q1 | $12.6M | Buy |
682,129
+24,461
| +4% | +$478K | ﹤0.01% | 1952 |
|
|
2016
Q4 | $12.4M | Buy |
657,668
+269,390
| +69% | +$5.51M | ﹤0.01% | 1956 |
|
|
2016
Q3 | $8.69M | Buy |
388,278
+8,839
| +2% | +$168K | ﹤0.01% | 2171 |
|
|
2016
Q2 | $6.76M | Sell |
379,439
-14,452
| -4% | -$234K | ﹤0.01% | 2275 |
|
|
2016
Q1 | $5.38M | Sell |
393,891
-2,023
| -0.5% | -$30.7K | ﹤0.01% | 2367 |
|
|
2015
Q4 | $7.64M | Buy |
395,914
+22,473
| +6% | +$449K | ﹤0.01% | 2195 |
|
|
2015
Q3 | $7.57M | Buy |
373,441
+68,499
| +22% | +$2.03M | ﹤0.01% | 2178 |
|
|
2015
Q2 | $10.1M | Buy |
304,942
+75,885
| +33% | +$2.08M | ﹤0.01% | 2062 |
|
|
2015
Q1 | $5.49M | Buy |
229,057
+16,472
| +8% | +$251K | ﹤0.01% | 2450 |
|
|
2014
Q4 | $2.6M | Sell |
212,585
-8,544
| -4% | -$88.4K | ﹤0.01% | 2933 |
|
|
2014
Q3 | $2M | Buy |
221,129
+35,770
| +19% | +$421K | ﹤0.01% | 3107 |
|
|
2014
Q2 | $2.18M | Buy |
185,359
+141,444
| +322% | +$1.92M | ﹤0.01% | 3043 |
|
|
2014
Q1 | $931K | Buy |
+43,915
| New | +$675K | ﹤0.01% | 3416 |
|
Other funds holding TVTX
AC
PA
VCM
NAMI
Northern Trust's TVTX Position: Q1 2026 in Review
Northern Trust increased its Travere Therapeutics (TVTX) stake by 2.6% in Q1 2026, buying an estimated $596K and bringing the position to 781,418 shares worth $23.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1581.
Northern Trust first reported a position in TVTX in Q1 2014 and has held it in 49 quarters since. The position peaked at $29.1M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.
- Northern Trust held 781,418 shares of Travere Therapeutics worth $23.2M as of Q1 2026.
- Northern Trust bought 19,945 Travere Therapeutics shares in Q1 2026, an estimated $596K.
- Travere Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #1581 holding.
- Northern Trust first reported a position in Travere Therapeutics in Q1 2014 and has held it in 49 quarters since.
- Northern Trust's Travere Therapeutics position peaked at $29.1M in Q4 2025.
- 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.